In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of ZyVersa Therapeutics Inc (NASDAQ: ZVSA) closed at $5.77 in the last session, up 15.63% from day before closing price of $4.99. In other words, the price has increased by $15.63 from its previous closing price. On the day, 8.05 million shares were traded. ZVSA stock price reached its highest trading level at $6.7 during the session, while it also had its lowest trading level at $5.15.
Ratios:
We take a closer look at ZVSA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 0.33 and its Current Ratio is at 0.33. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZVSA now has a Market Capitalization of 37898340 and an Enterprise Value of 1253182.
Stock Price History:
The Beta on a monthly basis for ZVSA is 0.66, which has changed by -0.96702856 over the last 52 weeks, in comparison to a change of 0.24191546 over the same period for the S&P500. Over the past 52 weeks, ZVSA has reached a high of $220.85, while it has fallen to a 52-week low of $4.44. The 50-Day Moving Average of the stock is -24.06%, while the 200-Day Moving Average is calculated to be -78.98%.
Shares Statistics:
According to the various share statistics, ZVSA traded on average about 253.58K shares per day over the past 3-months and 872484 shares per day over the past 10 days. Shares short for ZVSA as of 1713139200 were 46079 with a Short Ratio of 0.02, compared to 1710460800 on 64599. Therefore, it implies a Short% of Shares Outstanding of 46079 and a Short% of Float of 6.08.
Earnings Estimates
Currently, 2 analysts are dedicated to thoroughly evaluating and rating the performance of ZyVersa Therapeutics Inc (ZVSA) in the stock market.On average, analysts expect EPS of -$3.7 for the current quarter, with a high estimate of -$2 and a low estimate of -$5.4, while EPS last year was -$31.5. The consensus estimate for the next quarter is -$3.75, with high estimates of -$2.2 and low estimates of -$5.3.
Analysts are recommending an EPS of between -$7.4 and -$22.7 for the fiscal current year, implying an average EPS of -$15.05. EPS for the following year is -$94.9, with 2.0 analysts recommending between -$4.8 and -$185.0.
